Skip To Main Content
Michael Turner on Muck Rack

Michael Turner

As seen in: Fandom, Nature, Daily Express, MDPI, VICE UK, Analytical Chemistry, Seeking Alpha, Irish Independent, Science Magazine, Pediatrics and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Vitalik Buterin Eyes Indistinguishability Obfuscation for Collusion-Resistant Private Voting

|
By Michael Turner
| coinscreamer.com
Decentralized Autonomous Organizations (DAOs) and on-chain voting systems face a persistent, foundational paradox: public blockchains are radically transparent, but healthy democratic voting requires absolute privacy. Without confidentiality, voter transparency leads directly to bribery, collusion, and political coercion.
Open in Who Shared Issue with article?

Dynamic Boundary-Aware Mamba-Transformer for Fuzzy Tumor Margin Detection

|
By Michael Turner, Emily Chen, David Laurent, Sophia Martinez
| preprints.org
Submitted: 28 December 2025 You are already at the latest version Tumor boundary delineation is particularly challenging due to the presence of infiltrative margins, low-contrast regions, and ambiguous transitions between healthy and diseased tissue. DBMT-Net addresses these issues with a hybrid architecture that combines the global contextual modeling capability of Mamba with the fine-grained boundary refinement strength of a Transformer decoder.
Open in Who Shared Issue with article?

Point-of-Care Method T2Bacteria®Panel Enables a More Sensitive and Rapid Diagnosis of Bacterial Blood Stream Infections and a Shorter Time until Targeted Therapy Than Blood Culture

|
By Michael Turner, Theresa Mader, Tamara Clodi-Seitz, Sebastian Baumgartner
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 59 licensed articles (65 Total)